Single award · contract
Procurement and Late-Stage Development of Smallpox Antiviral Drug(s)
Award ID: 75A50118C00019
A single federal award, with both ends of the trail linked.
$626.5M
Total award value
Award 75A50118C00019 is a contract from the Department of Health and Human Services, $626.5M obligated, FY2018 to FY2029, for Procurement and Late-Stage Development of Smallpox Antiviral Drug(s). The work is performed in Oregon. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN13 (Health R&D Services; Health Care Services; Experimental Development). Source
Description
Procurement and Late-Stage Development of Smallpox Antiviral Drug(s) Igf::ot::igf
Award details
Award typeContract
PIID75A50118C00019
Action date2018
Period131 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceOregon →
CategoryNAICS 541714PSC AN13
Competed?Not recordedSource
Total (exact)$626,506,870
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.